Microbot Medical Inc.
MBOT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883975
No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −6 vs. previous quarter
- 71
- 13F valueReported value at the end of Q2 2026
- $22.1M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MBOT, Q2 2026
No superinvestor reported holding MBOT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Microbot Medical Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Microbot Medical Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Microbot Medical Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 2,906,810 | $5.67M | 0.00% | −2,715−0.1% | Reduced |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 1,268,453 | $2.47M | 0.00% | +1,268,453 | New |
| BlackRock, Inc. | 902,411 | $1.76M | 0.00% | +45,013+5.2% | Added |
| Geode Capital Management, LLC | 836,271 | $1.63M | 0.00% | +75,440+9.9% | Added |
| UBS Group AG | 806,847 | $1.57M | 0.00% | −10,098−1.2% | Reduced |
| DnB Asset Management AS | 677,498 | $1.32M | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 589,924 | $1.15M | 0.00% | +16,849+2.9% | Added |
| Marshall Wace, LLP | 541,963 | $1.06M | 0.00% | +60,918+12.7% | Added |
| Susquehanna International Group, LLP | 525,827 | $1.03M | 0.00% | −398,480−43.1% | Reduced |
| Vanguard Fiduciary Trust Co | 431,033 | $840.5K | 0.00% | +30,808+7.7% | Added |